Prophylactic and therapeutic HPV vaccines: current scenario and perspectives
Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …
cancer and other malignant cancers. Although early detection and treatment can be …
Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …
Perspectives for therapeutic HPV vaccine development
Background Human papillomavirus (HPV) infections and associated diseases remain a
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
An update on human papilloma virus vaccines: history, types, protection, and efficacy
Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide.
Early prevention with HPV vaccination is a safe and effective method against this disease …
Early prevention with HPV vaccination is a safe and effective method against this disease …
Vaccines for HPV-associated diseases
JM Skolnik, MP Morrow - Molecular Aspects of Medicine, 2023 - Elsevier
Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease
AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
Emerging human papillomavirus vaccines
B Ma, B Maraj, NP Tran, J Knoff, A Chen… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Identification of human papillomavirus (HPV) as the etiologic factor of cervical,
anogenital, and a subset of head and neck cancers has stimulated the development of …
anogenital, and a subset of head and neck cancers has stimulated the development of …
HPV vaccine: updates and highlights
CM De Oliveira, JHTG Fregnani, LL Villa - Acta cytologica, 2019 - karger.com
HPV is the most common sexually transmitted biological agent and is the cause of many
conditions in men and women, including precancer lesions and cancer. Three prophylactic …
conditions in men and women, including precancer lesions and cancer. Three prophylactic …
Recent developments in human papillomavirus (HPV) vaccinology
AL Williamson - Viruses, 2023 - mdpi.com
Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …
[HTML][HTML] Therapeutic vaccines for high-risk HPV-associated diseases
Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …